 My company has a study called the exoluminate study, which is basically a prospective registry study, and it's looking at, in particular, at people with a family history of pancreatic cancer, people who have one of the known germline, one known inherited mutations which raise their risk, like BRCA, raises your risk for pancreatic cancer, and people who've had a clinically suspicious finding, whether it's a nodule or a cyst found on an incidental x-ray or an episode of pancreatitis. These are the groups that can enroll in this study and they get free testing. I mean, it's not like we're gonna charge them. It doesn't cost them anything, but all they have to do is share their clinical information and allow us to take a blood sample three times.